Keywords: update, pharmacia, gets, approval, celebrex, follow-up, bextra
Update: Pharmacia gets US approval for Celebrex follow-up Bextra
Article | 20 November 2001
Pharmacia has been granted US Food and Drug Administration approvalfor Bextra (valdecoxib) tablets, its COX-2 specific inhibitor that is intended ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
